Supporting Information

Transcript

1 Supporting Information Enantioselective Epoxidation of Olefins with H 2 O 2 Catalyzed by Bioinspired Aminopyridine Manganese Complexes Duyi Shen,, Bin Qiu,, Daqian Xu, Chengxia Miao, Chungu Xia, and Wei Sun*, State Key Laboratory for Oxo Synthesis and Selective Oxidation, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou , PR China University of Chinese Academy of Sciences, Beijing , PR China wsun@licp.cas.cn Contents S1 General remarks S2 Synthesis and characterization of chiral N4 ligands and the corresponding Mn II complexes S3 General procedure for asymmetric epoxidation of olefin S4 Table S1. Screening the carboxylic acid for the AE of styrene. S5 Table S2. Asymmetric Epoxidation of Various Olefins by PMCP NMe2 Mn (C1a) and H 2 O 2. S6 The gram-scale experiment for asymmetric epoxidation of trans-stilbene S7 Characterization data of epoxides S8 References S9 Copies of HPLC spectra S10 Copies of GC spectra S11 Copies of NMR spectra

2 S1 General remarks All chemicals were purchased from commercial sources and used as received, unless noted otherwise. Anhydrous solvents were purified using standard methods. 1 H and 13 C NMR spectra were recorded using a Bruker Avance III 400MHz spectrometer. 1 H and 13 C NMR spectroscopic chemical shifts (δ = values) were given in ppm relative to tetramethylsilane as an internal or the solvent signal (for 1 H: CDCl 3, δ = 7.26 ppm). ESI-MS spectra were collected using an Agilent 6530 Q-TOF LC-MS. Optical rotation was recorded with a Perkin-Elmer 341 polarimeter (sodium lamp, 1-dm cuvette, c in g/100 ml, 20 o C). GC analysis for ee values and yields were determined with an Agilent 6820 GC or 7890 GC with a Beta dex TM 120 column and a CP-Chirasil-Dex CB column. HPLC analysis for ee values was performed on a Waters-Breeze system (2487 Dual λ Absorbance Detector and 1525 Binary HPLC Pump). Chiralpak OD, OB and OJ columns were purchased from Daicel Chemical Industries, LTD. The derivatives of trans-stilbene were synthesized by Wittig reactions and the racemic of epoxides were prepared with mcpba.

3 S2 Synthesis and characterization of chiral N4 ligands and the corresponding Mn II complexes Scheme S1. Synthesie of the Ligands. Intermediates 2 1, 3 1, 4 2, 5 3 were prepared according to the reported methods. The ligands L1a-1c were synthesized from 5 and corresponding Grignard reagents as our previously reported procedures. 3 Ligand (R,R)-PMCP (L2a) was synthesized according to our previously reported procedures. 3 Ligand L2b was prepared from (1R,2R)-N 1,N 2 -dimethylcyclohexane-1,2-diamine from and 3 according to the reported method. 4 (1R,2R)-N 1,N 2 -bis((4-(dimethylamino)pyridin-2-yl)methyl)-n 1,N 2 -dimethylcyclohexane-1,2-diami ne (L2a, MCP NMe 2 ) Light yellow solid; [α] 20 D = -71 (c = 0.11, CHCl 3 ) 1 H NMR (400 MHz, CDCl 3 ) δ 8.11 (d, J = 6.0 Hz, 2H), 6.92 (d, J = 2.6 Hz, 2H), 6.35 (dd, J = 6.0, 2.7 Hz, 2H), 3.75 (dd, J = 61.3, 14.2 Hz, 4H), 2.85 (s, 12H), (m, 2H), 2.33 (s, 6H), 1.97 (d, J = 12.6 Hz, 2H), (m, 2H), 1.26 (t, J = 10.2 Hz, 2H), (m, 2H). 13 C NMR (101 MHz, CDCl 3 ) δ 161.2, 154.0, 148.6, 105.5, 105.1, 64.4, 60.7, 39.0, 36.8, 25.9, HRMS calcd. for C24H39N6 [M+H] + : , found:

4 (1R,2R,N 1 E,N 2 E)-N 1,N 2 -bis((4-(dimethylamino)pyridin-2-yl)methylene)cyclohexane-1,2-diamine (5) Yellow solid. 1 H NMR (400 MHz, CDCl 3 ) δ 8.25 (s, 2H), 8.17 (d, J = 5.9 Hz, 2H), 7.09 (d, J = 2.7 Hz, 2H), 6.42 (dd, J = 6.0, 2.8 Hz, 2H), (m, 2H), 2.97 (s, 12H), 1.84 (dt, J = 21.6, 10.9 Hz, 6H), (m, 2H). 13 C NMR (101 MHz, CDCl 3 ) δ 162.3, 154.7, 149.2, 107.5, 103.7, 73.5, 39.2, 32.8, (1R,2R)-N 1,N 2 -bis((r)-(4-(dimethylamino)pyridin-2-yl)(phenyl)methyl)cyclohexane-1,2-diamine (6a) Orange solid. 1 H NMR (400 MHz, CDCl 3 ) δ 8.16 (d, J = 5.9 Hz, 2H), 7.55 (d, J = 7.2 Hz, 4H), 7.26 (t, J = 7.5 Hz, 4H), 7.17 (t, J = 7.3 Hz, 2H), 6.68 (d, J = 2.5 Hz, 2H), 6.32 (dd, J = 5.9, 2.6 Hz, 2H), 4.97 (s, 2H), 2.95 (s, 12H), (m, 2H), 2.05 (d, J = 12.6 Hz, 2H), 1.57 (d, J = 7.8 Hz, 2H), 1.05 (t, J = 10.1 Hz, 2H), 0.94 (ddd, J = 17.3, 10.2, 4.9 Hz, 2H). 13 C NMR (101 MHz, CDCl 3 ) δ 163.8, 154.9, 149.1, 143.5, 128.3, 127.8, 126.8, 105.1, 104.3, 65.9, 59.2, 39.1, 31.6, (1R,2R)-N 1,N 2 -bis((r)-(4-(dimethylamino)pyridin-2-yl)(phenyl)methyl)-n 1,N 2 -dimethylcyclohexa ne-1,2-diamine (L1a, PMCP NMe 2 ) Yellow solid; [α] 20 D = -100 (c = 0.2, CHCl 3 ) 1 H NMR (400 MHz, CDCl 3 ) δ 8.13 (d, J = 5.9 Hz, 2H), 7.63 (d, J = 7.3 Hz, 4H), 7.24 (t, J = 7.5 Hz, 4H), 7.17 (t, J = 7.3 Hz, 2H), 7.04 (d, J = 2.3 Hz, 2H), 6.35 (dd, J = 5.9, 2.4 Hz, 2H), 4.88 (s, 2H), 3.02 (s, 12H), 2.61 (d, J = 8.9 Hz, 2H), 2.20 (s, 6H), 1.86 (d, J = 12.4 Hz, 2H), 1.52 (d, J = 7.6 Hz, 2H), 1.08 (d, J = 8.8 Hz, 2H), 0.78 (t, J = 9.5 Hz, 2H). 13 C NMR (101 MHz, CDCl 3 ) δ 163.1, 155.0, 148.9, 142.1, 128.8, 128.1, 127.0, 105.3, 105.1, 77.4, 77.0, 76.7, 75.6, 65.9, 59.7, 39.2, 34.2, 25.5, HRMS calcd. for C36H47N6 [M+H] + : , found: (1R,2R)-N 1,N 2 -bis((r)-(4-(tert-butyl)phenyl)(4-(dimethylamino)pyridin-2-yl)methyl)-n 1,N 2 -dimet

5 hylcyclohexane-1,2-diamine (L1b, BPMCP NMe 2 ) Yellow solid; [α] 20 D = -184 (c = 0.1, CHCl 3 ) 1 H NMR (400 MHz, CDCl 3 ) δ 8.13 (d, J = 5.9 Hz, 2H), 7.50 (d, J = 8.2 Hz, 4H), 7.24 (d, J = 8.3 Hz, 4H), 7.08 (d, J = 2.3 Hz, 2H), 6.34 (dd, J = 5.8, 2.3 Hz, 2H), 4.88 (s, 2H), 3.01 (s, 12H), 2.64 (d, J = 8.8 Hz, 2H), 2.23 (s, 6H), 1.79 (d, J = 11.8 Hz, 2H), 1.50 (d, J = 7.2 Hz, 2H), 1.26 (s, 18H), 1.09 (d, J = 4.1 Hz, 2H), 0.79 (p, J = 10.8 Hz, 2H). 13 C NMR (101 MHz, CDCl 3 ) δ 163.9, 155.0, 149.4, 148.9, 138.8, 128.5, 124.9, 105.3, 104.9, 75.4, 60.0, 39.2, 34.4, 34.1, 31.4, 25.6, HRMS calcd. for C44H63N6 [M+H] + : , found: (1R,2R)-N 1,N 2 -bis((r)-(4-(dimethylamino)pyridin-2-yl)(naphthalen-1-yl)methyl)-n 1,N 2 -dimethylc yclohexane-1,2-diamine (L1c, 1-NMCP NMe 2 ) Yellow solid; [α] 20 D = -154 (c = 0.13, CHCl 3 ) 1 H NMR (400 MHz, CDCl 3 ) δ 8.73 (d, J = 6.9 Hz, 2H), 8.60 (d, J = 8.5 Hz, 2H), 8.17 (d, J = 6.0 Hz, 2H), 7.79 (d, J = 7.7 Hz, 2H), 7.68 (d, J = 8.1 Hz, 2H), (m, 6H), 6.98 (d, J = 2.3 Hz, 2H), 6.33 (dd, J = 6.0, 2.4 Hz, 2H), 5.80 (s, 2H), 2.94 (s, 12H), 2.72 (d, J = 8.9 Hz, 2H), 2.13 (s, 6H), 2.00 (d, J = 12.5 Hz, 2H), (m, 2H), (m, 2H), 0.69 (t, J = 9.8 Hz, 2H). 13 C NMR (101 MHz, CDCl 3 ) δ 163.2, 154.7, 148.6, 139.1, 133.8, 132.1, 128.6, 127.1, 126.6, 125.8, 125.7, 125.1, 124.3, 106.1, 105.4, 69.4, 60.0, 39.0, 35.5, 25.4, HRMS calcd. for C44H51N6 [M+H] + : , found: Scheme S2. Synthesis of the corresponding manganese (II) complexes C1a-c.

6 C1a, PMCP NMe 2 Mn, brown solid; [Mn II (L1a)(OTf) 2 ] HRMS calcd. for C37H46F3MnN6O3S [M-OTf] + : , found: C1b, BPMCP NMe 2 Mn, brown solid; [Mn II (L1b)(OTf) 2 ] HRMS calcd. for C45H62F3MnN6O3S [M-OTf] + : , found: C1c, NMCP NMe 2 Mn, brown solid; [Mn II (L1c)(OTf) 2 ] HRMS calcd. for C46H50F3MnN6O3S [M-OTf] + : , found: C2b, MCP NMe 2 Mn, brown solid; [Mn II (L2b)(OTf) 2 ] HRMS calcd. for C24H38MnN6 [M-2OTf] 2+ : , found:

7 S3 General procedure for asymmetric epoxidation of olefin. In a typical reaction, a MeCN (1 ml) solution of substrate (0.5 mmol), Mn catalyst ( mol%) and carboxylic acid ( mol%) was added in a 10 ml flask at room temperature without any inert-gas protection. Then H 2 O 2 ( equiv, diluted from a 30% aqueous solution in 0.5 ml of MeCN) was added via a syringe pump over 1 h with stirring at 30 o C. At this point, decane was added to the mixture as internal standard. The reaction was quenched with saturated NaHCO 3 aqueous solution, saturated Na 2 S 2 O 3 aqueous solution and extracted with ether. The organic layer was dried over anhydrous Na 2 SO 4 and then determined by GC and GC-MS or directly loaded on a column chromatography with silica gel to get pure products (Table 2, entries 4, 9-11 and 14; Table S2 and 1-7.). Specially, 0.3 mmol substrates and mixed solvent of MeCN and CH 2 Cl 2 (v: v = 1: 1) were adopted in the cases of stilbene, chalcone and their derivatives. S4 Table S1. Screening the Carboxylic Acid (CA) for the AE of Styrene. a entry CA GC conv (%) GC yield (%) ee (%) 1 AA MVA PBA CHA EBA EHA PVA ACA DMBA rac-ibu S-Ibu b D-CPA Boc-L-Pro a Reaction conditions: H 2 O 2 (30% aqueous solution, 1.3 equiv.) diluted with 0.5 ml of MeCN was delivered through syringe pump over 1 h to a stirred solution of PMCP NMe2 Mn, C1a catalyst (0.1 mol %), acid additives (25 mol %), internal standard (decane) and substrate (0.5 mmol) in 1.0 ml of MeCN at 30 o C. b The amount of CPA was 15 mol %.

8 S5 Table S2. Asymmetric epoxidation of various olefins by PMCP NMe2 Mn (C1a) and H 2 O 2. a entry substrate conv (%) Yield (%) b ee (%) c d R 1 = H, R 2 = Me d R 1 = Me, R 2 = H d R 1 = H, R 2 = Cl a Reaction conditions: For styrene derivatives, H 2 O 2 (30% aqueous solution, 1.3 equiv) diluted with 0.5 ml of MeCN was delivered through syringe pump over 1 h to a stirred solution of C1a (0.1 mol %), DMBA (25 mol %), internal standard (decane) and substrate (0.5 mmol) in 1.0 ml of MeCN at 30 o C; For stilbene derivatives, the scale of substrates were 0.3 mmol while the solvent was a mixture of MeCN and CH 2 Cl 2 (v:v = 1:1). b Isolated yields. c The ee values were measured by HPLC with chiral columns. d The reaction conditions were as follow, H 2 O 2 (30% aqueous solution, 2 equiv) diluted with 0.5 ml of MeCN was delivered through syringe pump over 1 h to a stirred solution of C1a (0.4 mol %), DMBA (100 mol %) and substrate (0.5 mmol) in 1.0 ml of MeCN in the air at -30 o C. S6 The gram-scale experiment for asymmetric epoxidation of trans-stilbene Substrate trans-stilbene (6 mmol, 1.08 g), Mn catalyst C1a (0.1 mol %), DMBA (25 mol %) were dissolved in a mixed solution (15 ml, MeCN:CH 2 Cl 2 = 1:2) and stirred at -30 o C. Then H 2 O 2 solution (1.3 equiv, diluted from a 30% aqueous solution in 5 ml MeCN) was added via a syringe pump over 1 h. After the dropping was completed, the reaction mixture was dried over anhydrous Na 2 SO 4. The solvent was eliminated at reduced pressure while the residue was purified by silica gel column chromatography to afford trans-stilbene oxide (68% yield, 88% ee) as white solid. Recrystallization of the crude product from hot petroleum ether afforded the epoxide with a 93% ee.

9 S7 Characterization data of epoxides 2-(p-Tolyl)oxirane (Table 2, entry 4) 5 O Oil (46.9 mg, 70% yield, 67% ee); [α] 20 D = +20 (c = 0.18, CHCl 3 ). 1 H NMR (400 MHz, CDCl 3 ) δ 7.17 (s, 4H), 3.84 (dd, J = 4.0, 2.6 Hz, 1H), 3.14 (dd, J = 5.4, 4.1 Hz, 1H), 2.80 (dd, J = 5.4, 2.6 Hz, 1H), 2.35 (s, 3H). 13 C NMR (101 MHz, CDCl 3 ) δ 138.0, 134.5, 129.2, 125.5, 52.4, 51.2, The optical purity was determined by HPLC (Chiralcel OD-H, 25 o C, hexane/isopropanol 99:1, flow rate: 0.5 ml/min, 220 nm, t r = min and min). trans-stilbene oxide (Table 2, entry 10) 6 Solid (50.6 mg, 86% yield, 88% ee); [α] 20 D = +273 (c = 0.31, CHCl 3 ). 1 H NMR (400 MHz, CDCl 3 ) δ (m, 10H), 3.87 (s, 2H). 13 C NMR (100 MHz, CDCl 3 ) δ 137.1, 128.6, 128.3, 125.5, The optical purity was determined by HPLC (Chiralcel OD-H, 25 o C, hexane/isopropanol 90:10, flow rate: 0.8 ml/min, 254 nm, t r = min and min). 2-(4-Fluorophenyl)-3-phenyloxirane (Table 2, entry 11) 7 Solid (51.4 mg, 80% yield, 88% ee); [α] 20 D = (c = 0.56, CHCl 3 ). 1 H NMR (400 MHz, CDCl 3 ) δ 7.34 (tdd, J = 14.0, 6.8, 1.6 Hz, 7H), 7.07 (t, J = 8.7 Hz, 2H), 3.84 (dd, J = 9.3, 1.6 Hz, 2H). 13 C NMR (101 MHz, CDCl 3 ) δ 141.0, 135.8, 135.5, 129.2, 128.4, 127.9, 127.8, 127.7, 127.6, 126.8, , 126.4, 68.7, The optical purity was determined by HPLC (Chiralcel OD-H, 25 o C, hexane/isopropanol 90:10, flow rate: 0.8 ml/min, 254 nm, t r = min and min). 2-Phenyl-3-(p-tolyl)oxirane (Table 2, entry 12) 7 Solid (35.9 mg, 57% yield, 80% ee); [α] 20 D = +200 (c = 0.27, CHCl 3 ). 1 H NMR (400 MHz, CDCl 3 ) δ (m, 5H), 7.21 (dd, J = 21.3, 8.0 Hz, 4H), (m, 2H), 2.36 (s, 3H). 13 C NMR (101 MHz, CDCl 3 ) δ 138.2, 137.3, 134.2, 129.3, 128.6, 128.3, 127.7, 127.6, 126.6, 125.2, 67.2, 63.1, The optical purity was determined by HPLC (Chiralcel OD-H, 25 o C, hexane/isopropanol 90:10, flow rate: 0.8 ml/min, 254 nm, t r = min and min).

10 2-Phenyl-3-(o-tolyl)oxirane (Table 2, entry 13) 8 Oil (49.2 mg, 78% yield, 90% ee); [α] 20 D = +74 (c = 0.14, CHCl 3 ). 1 H NMR (400 MHz, CDCl 3 ) δ (m, 6H), (m, 2H), (m, 1H), 3.92 (d, J = 1.9 Hz, 1H), 3.69 (d, J = 2.0 Hz, 1H), 2.28 (s, 3H). 13 C NMR (101 MHz, CDCl 3 ) δ , , , , , , , , , , 61.92, 50.91, The optical purity was determined by HPLC (Chiralcel OD-H, 25 o C, hexane/isopropanol 92:8, flow rate: 0.5 ml/min, 210 nm, tr = min and min). 2,3-Bis(4-(tert-butyl)phenyl)oxirane (Table 2, entry 14) 9 Solid (73.1 mg, 79% yield, 52% ee); [α] 20 D = (c = 1.11, CHCl 3 ). 1 H NMR (400 MHz, CDCl 3 ) δ 7.40 (d, J = 8.3 Hz, 2H), 7.28 (d, J = 8.3 Hz, 2H), 3.85 (s, 1H), 1.33 (s, 9H). 13 C NMR (101 MHz, CDCl 3 ) δ 151.4, 134.4, 125.5, 125.3, 62.7, 34.7, The optical purity was determined by HPLC (Chiralcel OD-H, 25 o C, hexane/isopropanol 90:10, flow rate: 0.8 ml/min, 254 nm, t r = min and min). cis-stilbene oxide (Table 2, entry 15) 10 Solid (mixture of cis- and trans-epoxides (7:3) 39.4 mg, 67% yield; trans-epoxide, 28% ee ). 1 H NMR (400 MHz, CDCl 3 ) δ 7.16 (s, 10H), 4.34 (s, 2H). 13 C NMR (101 MHz, CDCl 3 ) δ 134.4, 127.8, 127.5, 126.9, ,2,3-Triphenyloxirane (Table S2, entry 16) 6 Solid (40.0 mg, 49% yield, 64% ee); [α] 20 D = (c = 0.42, CHCl 3 ). 1 H NMR (400 MHz, CDCl 3 ) δ (m, 5H), (m, 5H), (m, 3H), 7.03 (dd, J = 6.5, 3.1 Hz, 2H), 4.32 (s, 1H). 13 C NMR (101 MHz, CDCl 3 ) δ 164.0, 161.6, 136.9, (d, J = 3.0 Hz), (d, J = 18.3 Hz), (d, J = 8.3 Hz), 125.5, 115.7, 115.5, 62.8, The optical purity was determined by HPLC (Chiralcel OD-H, 25 o C, hexane/isopropanol 80:20, flow rate: 1 ml/min, 254 nm, t r = min and min).

11 2,2-Dimethyl-2,7b-dihydro-1aH-oxireno[2,3-c]chromene-6-carbonitrile (Table 3, entry 20) 11 Solid (57.3 mg, 95% yield, 98% ee); [α] 20 D = -60 (c = 0.55, CHCl 3 ) 1 H NMR (400 MHz, CDCl 3 ) δ = 7.66 (d, J = 2.0 Hz, 1H), 7.53 (dd, J = 8.5, 2.1 Hz, 1H), 6.87 (d, J = 8.5 Hz, 1H), 3.91 (d, J = 4.3 Hz, 1H), 3.54 (d, J = 4.4 Hz, 1H), 1.60 (s, 3H), 1.30 (s, 3H); 13 C NMR (100 MHz, CDCl 3 ) δ = 156.5, 134.4, 133.8, 121.1, 119.0, 118.7, 104.3, 74.7, 62.3, 49.8, 25.5, The optical purity was determined by HPLC (Chiralcel OD-H, 25 o C, hexane/isopropanol 90:10, flow rate: 1 ml/min, 254 nm, t r = min and min). 2-Methyl-2,3-diphenyloxirane (Table S2, entry 1) 6 Solid (49.2 mg, 78% yield, 42% ee); [α] 20 D = (c = 0.31, CHCl 3 ) 1 H NMR (400 MHz, CDCl 3 ) δ (m, 2H), (m, 6H), (m, 2H), 3.97 (s, 1H), 1.46 (s, 3H). 13 C NMR (101 MHz, CDCl 3 ) δ 142.4, 136.0, 128.5, 128.2, (d, J = 16.2 Hz), 126.6, 125.2, 67.2, 63.1, The optical purity was determined by HPLC (Chiralcel OD-H, 25 o C, hexane/isopropanol 80:20, flow rate: 1 ml/min, 254 nm, t r = min and min). (3-Phenyloxiran-2-yl)(p-tolyl)methanone (Table S2, entry 2) 12 Solid (113.2 mg, 95% yield, 93% ee); [α] 20 D = (c = 0.6, CHCl 3 ) 1 H NMR (400 MHz, CDCl 3 ) δ 7.92 (d, J = 8.2 Hz, 2H), 7.39 (d, J = 4.8 Hz, 5H), 7.28 (d, J = 8.0 Hz, 2H), 4.28 (d, J = 1.9 Hz, 1H), 4.07 (d, J = 1.8 Hz, 1H), 2.42 (s, 3H). 13 C NMR (100 MHz, CDCl 3 ) δ 192.6, 145.1, 135.7, 133.1, 129.6, 129.0, 128.8, 128.5, 125.8, 61.0, 59.3, The optical purity was determined by HPLC (Chiralcel OB-H, 25 o C, hexane/isopropanol 90:10, flow rate: 1 ml/min, 254nm, t r = min and min). Phenyl(3-(p-tolyl)oxiran-2-yl)methanone (Table S2, entry 3) 13 Solid (107.2 mg, 90% yield, 98% ee); [α] 20 D = (c = 0.6, CHCl 3 ) 1 H NMR (400 MHz, CDCl 3 ) δ 8.00 (dd, J = 5.2, 3.3 Hz, 2H), (m, 1H), 7.49 (dd, J = 10.7, 4.8 Hz, 2H), 7.27 (d, J = 7.8 Hz, 2H), 7.22 (d, J = 8.1 Hz, 2H), 4.30 (d, J = 1.9 Hz, 1H), 4.04 (d, J = 1.8 Hz, 1H), 2.38 (s, 3H). 13 C NMR (100 MHz, CDCl 3 ) δ 139.1, 135.5, 134.0, 132.5, 129.5,

12 128.9, 128.3, 125.8, 61.1, 59.5, The optical purity was determined by HPLC (Chiralcel OD-H, 25 o C, hexane/isopropanol 90:10, flow rate: 1 ml/min, 254nm, t r = 7.70 min and 8.65 min). (4-Chlorophenyl)(3-phenyloxiran-2-yl)methanone (Table S2, entry 4) 13 Solid (121.6 mg, 94% yield, 90% ee); [α] 20 D = (c = 0.6, CHCl 3 ) 1 H NMR (400 MHz, CDCl 3 ) δ (m, 2H), (m, 2H), (m, 3H), (m, 2H), 4.24 (d, J = 1.9 Hz, 1H), 4.08 (d, J = 1.8 Hz, 1H). 13 C NMR (100 MHz, CDCl 3 ) δ 140.6, 135.2, 133.7, 129.8, 129.2, 128.8, 125.8, 61.1, The optical purity was determined by HPLC (Chiralcel OJ, 25 o C, hexane/isopropanol 90:10, flow rate: 1 ml/min, 254nm, t r =15.56 min and min). S8 References (1) Zhang, C. X.; Kaderli, S.; Costas, M.; Kim, E.; Neuhold, Y. M.; Karlin, K. D.; Zuberbuhler, A. D. Inorg. Chem. 2003, 42, (2) Comba, P.; Morgen, M.; Wadepohl, H. Inorg. Chem. 2013, 52, (3) Wu, M.; Wang, B.; Wang, S.; Xia, C.; Sun, W. Org. Lett. 2009, 11, (4) Cusso, O.; Garcia-Bosch, I.; Ribas, X.; Lloret-Fillol, J.; Costas, M. J. Am. Chem. Soc. 2013, 135, (5) Dai, W.; Shang, S.; Chen, B.; Li, G.; Wang, L.; Ren, L.; Gao, S. J. Org. Chem. 2014, 79, (6) Wang, Z.-X.; Tu, Y.; Frohn, M.; Zhang, J.-R.; Shi, Y. J. Am. Chem. Soc. 2007, 119, (7) Niwa, T.; Nakada, M. J. Am. Chem. Soc. 2012, 134, (8) Illa, O.; Namutebi, M.; Saha, C.; Ostovar, M.; Chen, C. C.; Haddow, M. F.; Nocquet-Thibaut, S.; Lusi, M.; McGarrigle, E. M.; Aggarwal, V. K. J. Am. Chem. Soc. 2013, 135, (9) Gelalcha, F. G.; Bitterlich, B.; Anilkumar, G.; Tse, M. K.; Beller, M. Angew. Chem. Int. Ed. 2007, 46, (10) Chatterjee, D. J. Mol. Catal. A-Chem. 2009, 310, 174. (11) Shen, D.; Miao, C.; Wang, S.; Xia, C.; Sun, W. Eur. J. Inorg. Chem. 2014, (12) Lu, J.; Xu, Y.-H.; Liu, F.; Loh, T.-P. Tetrahedron Lett. 2008, 49, (13) Li, Y.; Liu, X.; Yang, Y.; Zhao, G. J. Org. Chem. 2007, 72, 288.

13 S9 Copies of HPLC spectra 2-(p-Tolyl)oxirane (Table 2, entry 4, 67% ee) O Chiralcel OD-H, 25 o C, hexane/isopropanol 99:1, flow rate: 0.5 ml/min, 220 nm, t r = min and min AU Minutes AU Minutes

14 trans-stilbene oxide (Table 2, entry 10, 88% ee) O Chiralcel OD-H, 25 o C, hexane/isopropanol 90:10, flow rate: 0.8 ml/min, 254 nm, t r = min and min AU Minutes AU Minutes trans-stilbene oxide (Scheme 2, Recrystallization, 93% ee) AU Minutes

15 2-(4-Fluorophenyl)-3-phenyloxirane (Table 2, entry 11, 88% ee) O F Chiralcel OD-H, 25 o C, hexane/isopropanol 90:10, flow rate: 0.8 ml/min, 254 nm, t r = min and min AU Minutes AU Minutes

16 2-Phenyl-3-(p-tolyl)oxirane (Table 2, entry 12, 80% ee): O Chiralcel OD-H, 25 o C, hexane/isopropanol 90:10, flow rate: 0.8 ml/min, 254 nm, t r = min and min AU Minutes AU Minutes

17 2-Phenyl-3-(o-tolyl)oxirane (Table 2, entry 13, 90% ee) Chiralcel OD-H, 25 o C, hexane/isopropanol 92:8, flow rate: 0.5 ml/min, 210 nm, tr = min and min. A U Minutes Name Retention Time Peak Type Area % Area Height % Height Unknown Unknown A U Minutes Name Retention Time Peak Type Area % Area Height % Height Unknown Unknown

18 2,3-Bis(4-(tert-butyl)phenyl)oxirane (Table 2, entry 14, 52% ee) t-bu t-bu O Chiralcel OD-H, 25 o C, hexane/isopropanol 90:10, flow rate: 0.8 ml/min, 254 nm, t r = min and min AU Minutes AU Minutes

19 2,2,3-Triphenyloxirane (Table 2, entry 16, 63% ee) Ph O Chiralcel OD-H, 25 o C, hexane/isopropanol 80:20, flow rate: 1 ml/min, 254 nm, t r = min and min AU Minutes AU Minutes

20 2,2-Dimethyl-2,7b-dihydro-1aH-oxireno[2,3-c]chromene-6-carbonitrile (Table 2, entry 20, 98% ee) NC O O Chiralcel OD-H, 25 o C, hexane/isopropanol 90:10, flow rate: 1 ml/min, 254 nm, t r = min and min AU Minutes AU Minutes

21 2-Methyl-2,3-diphenyloxirane (Table S2, entry 1, 42% ee) O Chiralcel OD-H, 25 o C, hexane/isopropanol 80:20, flow rate: 1 ml/min, 254 nm, t r = min and min AU Minutes AU Minutes

22 (3-Phenyloxiran-2-yl)(p-tolyl)methanone (Table S2, entry 2, 93% ee) O O Chiralcel OB-H, 25 o C, hexane/isopropanol 90:10, flow rate: 1 ml/min, 254nm, t r = min and min AU Minutes AU Minutes

23 Phenyl(3-(p-tolyl)oxiran-2-yl)methanone (Table S2, entry 3, 98% ee) O O Chiralcel OD-H, 25 o C, hexane/isopropanol 90:10, flow rate: 1 ml/min, 254nm, t r = 7.70 min and 8.65 min AU Minutes AU Minutes 8.598

24 (4-Chlorophenyl)(3-phenyloxiran-2-yl)methanone (Table S2, entry 4, 90% ee) O O Cl Chiralcel OJ, 25 o C, hexane/isopropanol 90:10, flow rate: 1 ml/min, 254nm, t r =15.56 min and min AU Minutes AU Minutes

25 S10 Copies of GC spectra Styrene oxide (Table 2, entry 1, 78% ee) O The optical purity was determined by Agilent 7890A with a CP-Chirasil-Dex CB column (90 o C isothermal for 5 minutes, 8 o C/min, 170 o C for 10 minutes, t r = and min). Peak at retention time around 9.5 min belongs to internal standard decane. Peak [#] RetTime [min] Type Area [%] BB BB Peak [#] RetTime [min] Type Area [%] BB BB

26 2-(4-Fluorophenyl)oxirane (Table 2, entry 2, 78% ee) O F The optical purity was determined by Agilent 7890A with a CP-Chirasil-Dex CB column (90 o C isothermal for 3 minutes, 10 o C/min, 170 o C for 10 minutes, t r = min and min). Peak at retention time around 7 min belongs to internal standard decane. Peak [#] RetTime [min] Type Area [%] BB BB Peak [#] RetTime [min] Type Area [%] BB BB

27 2-(4-Chlorophenyl)oxirane (Table 2, entry 3, 76% ee) O Cl The optical purity was determined by Agilent 7890A with a CP-Chirasil-Dex CB column (90 o C isothermal for 3 minutes, 10 o C/min, 170 o C for 10 minutes, t r = min and min). Peak at retention time around 7 min belongs to internal standard decane. Peak [#] RetTime [min] Type Area [%] BB BB Peak [#] RetTime [min] Type Area [%] BB BB

28 2-(m-Tolyl)oxirane (Table 2, entry 5, 77% ee) O The optical purity was determined by Agilent 7890A with a CP-Chirasil-Dex CB column (90 o C isothermal for 3 minutes, 10 o C/min, 170 o C for 10 minutes, t r = min and min). Peak at retention time around 7 min belongs to internal standard decane. Peak [#] RetTime [min] Type Area [%] MM MM Peak [#] RetTime [min] Type Area [%] BV VV

29 2-(o-Tolyl)oxirane (Table 2, entry 6, 80% ee) O The optical purity was determined by Agilent 7890A with a CP-Chirasil-Dex CB column (90 o C isothermal for 3 minutes, 10 o C/min, 170 o C for 10 minutes, t r = min and min). Peak at retention time around 7 min belongs to internal standard decane. Peak [#] RetTime [min] Type Area [%] MM MM Peak [#] RetTime [min] Type Area [%] BB BV

30 2-Methyl-3-phenyloxirane (Table 2, entry 7, 93% ee) O The optical purity was determined by Agilent 7890A with a CP-Chirasil-Dex CB column (90 o C isothermal for 3 minutes, 10 o C/min, 170 o C for 10 minutes, t r = min and min). Peak at retention time around 7 min belongs to internal standard decane. Peak [#] RetTime [min] Type Area [%] BB BB Peak [#] RetTime [min] Type Area [%] BB BB

31 2-Methyl-3-phenyloxirane (Table 2, entry 8, 2% ee) O The optical purity was determined by Agilent 7890A with a CP-Chirasil-Dex CB column (90 o C isothermal for 25 minutes, 10 o C/min to 170 o C for 15 minutes t r = min and min).

32 2,2-Dimethyl-3-phenyloxirane (Table 2, entry 9, 52% ee) O The optical purity was determined by Agilent 7890A with a CP-Chirasil-Dex CB column (80 o C isothermal for 3 minutes, 10 o C/min, 170 o C for 10 minutes, t r = min and min). Peak at retention time around 7 min belongs to internal standard decane. Peak [#] RetTime [min] Type Area [%] MM m MM m Peak [#] RetTime [min] Type Area [%] BV VB

33 2-Cyclohexyloxirane (Table 2, entry 17, 45% ee) O The optical purity was determined by Agilent 7890A with a CP-Chirasil-Dex CB column (90 o C isothermal for 5 minutes, 8 o C/min, 170 o C for 10 minutes, t r = and min). Peak at retention time around 9.5 min belongs to internal standard decane. Peak [#] RetTime [min] Type Area [%] BV VB Peak [#] RetTime [min] Type Area [%] BV VB

34 2-Butyl-3-methyloxirane (Table 2, entry 18, 54% ee) O The optical purity was determined by Agilent 7890A with a CP-Chirasil-Dex CB column (60 o C isothermal for 3 minutes, 3 o C/min, 170 o C for 10 minutes, t r = min and min). Peak [#] RetTime [min] Type Area [%] BV VB Peak [#] RetTime [min] Type Area [%] BV VB

35 2-hexyloxirane (Table 2, entry 19, 31% ee) O The optical purity was determined by Agilent 7890A with a CP-Chirasil-Dex CB column (45 o C isothermal for 50 minutes, 5 o C/min, 80 o C for 2 minutes, 10 o C/min, 170 o C for 15 minutes t r = min and max).

36 S11 Copies of NMR spectra (1R,2R,N 1 E,N 2 E)-N 1,N 2 -bis((4-(dimethylamino)pyridin-2-yl)methylene)cyclohexane-1,2-diamine (5)

37 (1R,2R)-N 1,N 2 -bis((4-(dimethylamino)pyridin-2-yl)methyl)-n 1,N 2 -dimethylcyclohexane-1,2-diami ne (L2b)

38 (1R,2R)-N 1,N 2 -bis((r)-(4-(dimethylamino)pyridin-2-yl)(phenyl)methyl)cyclohexane-1,2-diamine (6a)

39 (1R,2R)-N 1,N 2 -bis((r)-(4-(dimethylamino)pyridin-2-yl)(phenyl)methyl)-n 1,N 2 -dimethylcyclohexa ne-1,2-diamine (L1a)

40 (1R,2R)-N 1,N 2 -bis((r)-(4-(tert-butyl)phenyl)(4-(dimethylamino)pyridin-2-yl)methyl)-n 1,N 2 -dimet hylcyclohexane-1,2-diamine (L1b)

41 (1R,2R)-N 1,N 2 -bis((r)-(4-(dimethylamino)pyridin-2-yl)(naphthalen-1-yl)methyl)-n 1,N 2 -dimethylc yclohexane-1,2-diamine (L1c)

42 2-(p-Tolyl)oxirane (Table 2, entry 4)

43 trans-stilbene oxide (Table 2, entry 10)

44 2-(4-Fluorophenyl)-3-phenyloxirane (Table 2, entry 11)

45 2-Phenyl-3-(p-tolyl)oxirane (Table 2, entry 12)

46 2-Phenyl-3-(o-tolyl)oxirane (Table 2, entry 13)

47 2,3-Bis(4-(tert-butyl)phenyl)oxirane (Table 2, entry 14)

48 cis-stilbene oxide (Table 2, entry 15)

49 2,2,3-Triphenyloxirane (Table 2, entry 16)

50 2,2-Dimethyl-2,7b-dihydro-1aH-oxireno[2,3-c]chromene-6-carbonitrile (Table 2, entry 20)

51 2-Methyl-2,3-diphenyloxirane (Table S2, entry 1)

52 (3-Phenyloxiran-2-yl)(p-tolyl)methanone (Table S2, entry 2)

53 Phenyl(3-(p-tolyl)oxiran-2-yl)methanone (Table S2, entry 3)

54 (4-Chlorophenyl)(3-phenyloxiran-2-yl)methanone (Table S2, entry 4)